Sign In
Buy ADIL
$2.71
+0.110 (+4.23%)
At Close: Jun 22, 2026
Adial Pharmaceuticals CEO Selected as a Luncheon Keynote Speaker for the 2020 Wall Street Conference and Retreat
02:15pm, Friday, 14'th Feb 2020
CHARLOTTESVILLE, VA / ACCESSWIRE / February 14, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL;ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addictio
Adial Pharmaceuticals Commences Phase 3 Trial of AD04 for Alcohol Use Disorder
05:30pm, Thursday, 06'th Feb 2020
CHARLOTTESVILLE, VA / ACCESSWIRE / February 6, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addictio
Adial Pharmaceuticals Receives Approval to Commence Phase 3 Trial in Finland
02:15pm, Thursday, 09'th Jan 2020
CHARLOTTESVILLE, VA / ACCESSWIRE / January 9, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction
Need To Know: Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Insiders Have Been Buying Shares
10:36am, Monday, 30'th Dec 2019
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
Adial Pharmaceuticals Submits Clinical Trial Applications in Six Additional European Countries
02:30pm, Thursday, 19'th Dec 2019
CHARLOTTESVILLE, VA / ACCESSWIRE / December 19, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addict
CHARLOTTESVILLE, VA / ACCESSWIRE / December 16, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addicti
JNUG, TVIX, VCYT, AAXN, IIN, WTW
12:00am, Friday, 04'th Jan 2019
Stocks Analysis by Harry Boxer covering: Intuitive Surgical Inc, Axon Enterprise Inc, IntriCon Corporation, WW International Inc. Read Harry Boxer's latest article on Investing.com
